Company Filing History:
Years Active: 2008-2014
Title: Todd S Barry: Innovator in Chronic Lymphocytic Leukemia Research
Introduction
Todd S Barry is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of chronic lymphocytic leukemia (CLL) research. With a total of 3 patents, his work has been instrumental in advancing the understanding of this disease.
Latest Patents
One of Todd's latest patents focuses on ZAP-70 expression as a marker for chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL). It has been surprisingly found that ZAP-70 expression, both at the protein and mRNA levels, is indicative of clinical subgroups of CLL/SLL patients. In particular, high ZAP-70 expression is indicative of Ig-unmutated CLL/SLL. Methods are provided for discriminating between clinical subgroups of CLL/SLL by determining whether subjects overexpress ZAP-70 mRNA or protein.
Career Highlights
Todd S Barry is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to focus on critical research that impacts patient care and treatment options.
Collaborations
Some of his notable coworkers include Louis M Staudt and Andreas Rosenwald. Their collaborative efforts have further enhanced the research landscape in the field of hematology.
Conclusion
Todd S Barry's innovative work in the realm of chronic lymphocytic leukemia has paved the way for new diagnostic methods and treatment strategies. His contributions continue to influence the medical community and improve patient outcomes.